Eric Joseph Daniels insider trades

Open-market stock purchases and sales by Eric Joseph Daniels, Chief Development Officer at Plus Therapeutics, Inc, from SEC Form 4 filings since Oct 21, 2021.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -48%.

Recent trades

DateStockTradeValue
Apr 20, 2026PSTV Plus Therapeutics, IncBought (not open market)—
Apr 1, 2026KPRX Kiora Pharmaceuticals IncSold (not open market)$1.8K
Mar 6, 2026KPRX Kiora Pharmaceuticals IncBought (not open market)—
Mar 6, 2026KPRX Kiora Pharmaceuticals IncBought (not open market)—
Mar 3, 2026KPRX Kiora Pharmaceuticals IncSold (not open market)$481

Companies traded

  • PSTV Plus Therapeutics, Inc: other filings, last Apr 20, 2026
  • KPRX Kiora Pharmaceuticals Inc: 1 buy, last Apr 1, 2026

Get free alerts when Eric Joseph Daniels files a new trade →